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Abstract
Background: Tau phosphorylation and dephosphorylation regulate in a poorly understood manner its physiological role of
microtubule stabilization, and equally its integration in Alzheimer disease (AD) related fibrils. A specific phospho-pattern will
result from the balance between kinases and phosphatases. The heterotrimeric Protein Phosphatase type 2A encompassing
regulatory subunit PR55/Ba (PP2AT55a) is a major Tau phosphatase in vivo, which contributes to its final phosphorylation
state. We use NMR spectroscopy to determine the dephosphorylation rates of phospho-Tau by this major brain
phosphatase, and present site-specific and kinetic data for the individual sites including the pS202/pT205 AT8 and pT231
AT180 phospho-epitopes.
Methodology/Principal Findings: We demonstrate the importance of the PR55/Ba regulatory subunit of PP2A within this
enzymatic process, and show that, unexpectedly, phosphorylation at the pT231 AT180 site negatively interferes with the
dephosphorylation of the pS202/pT205 AT8 site. This inhibitory effect can be released by the phosphorylation dependent
prolyl cis/trans isomerase Pin1. Because the stimulatory effect is lost with the dimeric PP2A core enzyme (PP2AD) or with a
phospho-Tau T231A mutant, we propose that Pin1 regulates the interaction between the PR55/Ba subunit and the AT180
phospho-epitope on Tau.
Conclusions/Significance: Our results show that phosphorylation of T231 (AT180) can negatively influence the
dephosphorylation of the pS202/pT205 AT8 epitope, even without an altered PP2A pool. Thus, a priming
dephosphorylation of pT231 AT180 is required for efficient PP2AT55a-mediated dephosphorylation of pS202/pT205 AT8.
The sophisticated interplay between priming mechanisms reported for certain Tau kinases and the one described here for
Tau phosphatase PP2AT55a may contribute to the hyperphosphorylation of Tau observed in AD neurons.
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Introduction
Phosphorylation/dephosphorylation of the neuronal microtu-
bule associated protein Tau regulates in a complex manner its
capacity to assemble tubulin into microtubules. It is also associated
with the presence of pathological fibrils in neurons of AD patients,
which are mainly composed of hyperphosphorylated Tau. Mono-
clonal antibodies such as AT180 and AT8, recognizing respectively
the pT231 [1] and pS202/pT205 [2] Tau phospho-motifs, are
available for post-mortem diagnostics of the disease progression,
and can define the neurofibrillary lesions at different stages of the
disease [3]. The spatial hierarchy observed is equally accompanied
by a temporal progression of the phosphorylation pattern of Tau.
The T231 site, for example, becomes phosphorylated early in the
disease, and precedes phosphorylation at the pS202/pT205 AT8
site [4], [5].
The phosphorylation of Tau is a reversible process, which
implies that the pathological hyperphosphorylation can result
from a deregulation of kinase and/or phosphatase activity. Intense
research has increased our understanding of the kinases that
generate certain phosphorylation events, as well as their complex
regulation. Calpain cleavage of the regulatory p35 subunit of
CDK5 results in a membrane detachment of the resulting CDK5/
p25 complex [6]. Although the intrinsic catalytic activity of this
complex towards Tau seems not different from that of CDK5/p35
[7], the cytosolic presence of the CDK5/p25 complex might play
a role in Tau’s phosphorylation. As a downstream event, T231
phosphorylation by GSK3b requires priming of the S235 site by
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enzyme through phosphorylation of the latter at its S9 [10].
One major brain phosphatase that dephosphorylates phospho-
Tau is the Protein Phosphatase 2A (PP2A) [11], [12], [13], a
multimeric enzyme consisting at least of a dimeric core enzyme
(hereafter abbreviated PP2AD) constituted of a catalytic subunit (C
subunit) and a scaffolding subunit (A subunit). This heterodimer
(PP2AD) can further integrate a regulatory B-type subunit to form
a heterotrimeric PP2A complex (PP2AT) [14], [15]. The particular
regulatory B-type subunit, that exhibits itself specific spatial and
temporal expression patterns [16], [17], regulates the catalytic
activity and specificity of the heterotrimeric PP2A towards the
target phospho-protein(s) [18]. One of the most prominent neuro-
nal forms, highly expressed together with the PP2A catalytic C
subunit in neurons, is the B-type subunit PR55/Ba, whose crystal
structure in the heterotrimeric enzyme (hereafter abbreviated
PP2AT55a) has recently been determined [19]. A reduced PP2A
activity was shown to induce hyperphosphorylation of Tau, in-
cluding at the pS202/pT205 AT8 site in transgenic mice [20], and
has equally been shown in AD at various levels. Firstly, in the
hippocampus, a decrease in mRNA expression of the PP2A cata-
lytic C subunit and various B-type subunits has been observed
[21]. Secondly, at the protein level, a decreased level of the PR55/
Ba subunit due to an increased turnover is associated with the AD
pathology [22].
The regulation of PP2A is complex, and involves more than the
subunits of the holoenzyme. Polycations can stimulate the activity
of PP2A through a direct interaction with the enzyme. As the
stimulation is dependent on the type of holoenzyme, the
interaction involves the regulatory B-type subunit [23], although
an interaction with the substrate has also been reported [24]. An
inhibitory interaction was described for a-endosulfine and Arpp-
19, two small proteins that after phosphorylation by the Greatwall
kinase interact with the PR55/Bd regulatory subunit, and thereby
shut down the activity of PP2A [25], [26]. Another regulatory
factor for PP2A activity is Pin1, a phosphorylation dependent
prolyl cis/trans isomerase that targets specifically the pS/pT-P
motifs. This isomerase was shown to stimulate the dephosphor-
ylation of Tau by PP2A [27]. Pin1
2/2 mice show indeed a
decreased phosphatase activity towards pS/pT-P motifs and an
accumulation of both the pS202/pT205 AT8 and pT231/pS235
AT180 epitopes [28].
Kinases and phosphatases can hence regulate the phosphory-
lation/dephosphorylation of Tau in a complex and concerted
manner, whereby this intricate feedback can in vivo control the
final phosphorylation level of Tau [29]. Our present work aims to
better define the molecular role of PP2A and Pin1 in this process.
We first address the question of whether the different phosphor-
ylation sites of Tau are independent with respect to PP2A cata-
lyzed dephosphorylation, or whether the equivalent of a priming
mechanism described for certain kinases exists also for some
dephosphorylation reactions. Secondly, we investigate the role of
Pin1 in stimulating this PP2A-catalyzed dephosphorylation activity
towards specific sites. We use Tau in vitro phosphorylated by the
activated CDK2/CycA3 complex to study the effect of PP2A on
its dephosphorylation. We showed previously that CDK2/CycA3
action at the AT180 epitope is equivalent to that of the combined
CDK5/p25 and GSK3b kinases and can generate in a robust
manner the pS202/pT205 AT8 and pT231/pS235 AT180 epi-
topes on Tau [30], [31]. We use NMR spectroscopy as an analy-
tical technique that provides a direct and quantitative view on all
phosphorylation events in the full length protein [30], [32]. The
dephosphorylation reaction directly performed in the NMR tube
allows kinetic monitoring of the individual phosphorylation sites in
one single experiment. We reveal a subtle regulation of PP2AT55a
activity towards the Tau pS202/pT205 AT8 site by the phos-
phorylation status of T231, whereby phosphorylation of the latter
T231 site negatively interferes with the PP2A catalyzed dephos-
phorylation of pS202. In addition, we find that Pin1 releases this
negative feedback between the pT231 and pS202/pT205 AT8
epitopes. Our findings define an additional level of molecular
regulation of the PP2A phosphatase towards the phosphorylated
Tau protein, whereby the interplay between kinase and phospha-
tase activity can potentially lead to a stable hyperphosphorylated
state of Tau that characterizes AD affected neurons.
Results
Specificity of the heterotrimeric PP2AT55a for Pro-directed
CDK2/CycA3 phospho-sites of Tau
We previously showed that the recombinant CDK2/CycA3
complex generates robust and reproducible phosphorylation of
Tau at AD-specific epitopes, with high levels of phosphate
incorporation at pS202-pT205 and pT231-pS235 ([30]; Fig.
S1), recognized respectively by the diagnostic AT8 [1] and AT180
[2] AD-specific monoclonal antibodies. Additional phosphoryla-
tion events were observed at position T153 (70–80%), S199 (70–
80%) and S404 (50–60%). The heterotrimeric PP2AT55a complex
composed of the scaffolding A subunit, the catalytic C subunit and
the regulatory PR55/Ba subunit, was added to this CDK2/
CycA3-phosphorylated Tau441 sample (phospho-Tau) directly in
the NMR tube (Fig. 1). Consecutive [
1H,
15N] Heteronuclear
Single Quantum Correlation spectra (HSQC; hereafter named 2D
Figure 1. Dephosphorylation of phospho-Tau by the hetero-
trimeric PP2AT55a. Comparison of the [
1H,
15N] 2D spectrum of the
CDK2/CycA3 phospho-Tau (20 mM, in gray) and same sample incubated
16 hours at 25uC (293K) with 1U of PP2AT55a enzyme (superimposed in
red). Cross peaks of the amide function of the corresponding
phosphorylated residues are labelled as well as A152(T153 or pT153)
and T205(pS202) resonances. Regions of the spectrum enlarged in Fig. 2,
3 and 5 are boxed.
doi:10.1371/journal.pone.0021521.g001
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one hour time resolution, corresponding to the acquisition time of
a single 2D spectrum (Fig. 2, Data S1). Integration of a peak
surface for a given resonance in each 2D spectrum during this
in-spectrometer dephosphorylation reaction gives information on the
kinetics of the modification of the corresponding amino acid
(Fig. 2). Because phosphorylation does not only affect the amide
resonance of the modified amino acid but also that of its neigh-
bours, the same reaction can in favourable cases be followed on
different cross peaks. The A152 amide peak resonates for example
at slightly different frequencies dependent on the phosphoryla-
tion status of T153, and the same enzymatic reaction could be
followed as the decrease of the pT153 or the A152(pT153) amide
cross peaks, but equally as the increase of the A152(T153) amide
correlation (Fig. 2). Dephosphorylation of pT205 also followed an
exponential trend with a similar time constant (Table 1) that was
best monitored by the unphosphorylated T205 resonance(s)
(Fig. 3), located in a relatively sparse region of the spectrum [33].
Initially, no peak appears at its exact resonance position in the
unphosphorylated Tau protein, but we rather observe two in-
termediate peaks corresponding to T205(pS202) with a further
splitting due to the phosphorylation state of S199 (Fig. 3A). This
assignment was validated by a dephosphorylation experiment on
the phospho-TauS199A/S202A double mutant, where the inter-
mediate forms do not appear, but where we recover immediately
the T205 resonance at its position in the unmodified Tau spectrum
(Fig. 3B). When increasing the phosphatase concentration by a
factor of 3.5, a partial dephosphorylation of the complete AT8
epitope on wild type phospho-Tau could be obtained, with 30% of
the intensity at the position of T205(S202) after 16 hours of
incubation at 25uC( Fig. 3C). This latter observation also verifies
that we do monitor the enzymatic reaction catalysed by PP2AT55a
and not a spontaneous dephosphorylation under our NMR con-
ditions. In addition to the fast dephosphorylation observed for
pT153 and pT205 with the phosphate almost completely removed
by 3.5 units of PP2AT55a after the first two spectra, two additional
classes of residues could be distinguished. The first one contains
pT231 and pS404, and is characterized by very slow kinetics with
onlya marginal reductionofthephospho-resonanceafteronenight.
The second group shows intermediate dephosphorylation kinetics,
and concerns pS199, pS202 and pS235 (Fig. 1–4 and Table 1).
Dephosphorylation of phospho-Tau by the PP2AD core
enzyme
Several reports have shown the implication of the PR55/Ba
regulatory subunit in the substrate anchoring and enzyme
efficiency of PP2AT55a [19], [34]. In order to evaluate whether
the dimeric enzyme PP2AD, composed of the A and C subunits
without any B-type subunit, would maintain a phosphatase
Figure 2. Kinetic of dephosphorylation of phospho-Tau by the heterotrimeric PP2AT55a. Panels from left to right Control 2D spectrum of
phospho-Tau before addition of PP2AT55a (t=0 min.), second (t=120 min.) and sixth 2D spectrum (t=300 min.) in the serie after addition of PP2AT55a
(1U). A152(pT153) and A152(T153) stand for the amide resonance of A152 next to a pT153 or a T153 residue in the Tau molecule, respectively. A box
is drawn around a peak (see red box around pT153) and is replicated in each spectrum that corresponds to a time-point of the reaction. The surface
of the peak inside this box corresponds to an integral value or data-point in the graph on the right. This graph shows normalized integral values
plotted as a function of time (min.) for pT153 (black diamonds), A152(pT153) (open squares) and A152(T153) (black dots). Data are fitted with mono-
exponential curves characterized by the constant T (min.), indicated on the x-axis by a red arrow and reported in Table 1.
doi:10.1371/journal.pone.0021521.g002
Table 1. Specificity of dephosphorylation of the CDK2/CycA3
phospho-sites of Tau by the PP2AT55a and PP2AD phosphatases.
Tau w.t. TauT231A
Trimer (1 U) Trimer (3.5 U) Dimer (3.5 U) Trimer (1 U)
pT153 170 60 200 75
pS199 240 (30%) 220 (60%) 260 (45%) 200 (40%)
pS202 n.d. 300 (25%) n.d. 200
pT205 160 55 120 65
pT231 n.d. n.d. n.d. n.d.
pS235 n.d. 500 (40%) n.d. 175 (50%)
pS404 n.d. n.d. n.d. n.d.
Integral values of the resonances during a representative dephosphorylation
experiment in the spectrometer are fitted with mono-exponential functions of
type Integral = e
(-t/T) or 1-(e
-(t/T)) with time t and constant T in min, reported in
the Table.
Percentage in brackets (): extent of dephosphorylation if not complete.
n.d.: not dephosphorylated.
doi:10.1371/journal.pone.0021521.t001
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For an identical enzyme activity (3.5 units) of PP2AD heterodimer
and PP2AT55a heterotrimer as measured with phosphorylase a as
substrate, the dephosphorylation rate at all phospho-sites of Tau
was slower for the PP2AD dimer (Table 1). For pT153, we found
a three-fold slower rate, and a two-fold slow-down for pT205.
Significantly, dephosphorylation of pS202 at the AT8 epitope,
such as partially (25%) obtained with 3.5 units of PP2AT55a after
16 hours of incubation at 25uC, did not occur at all with the same
amount of PP2AD (Fig. 3D).
Dephosphorylation of the mutant phospho-Tau T231A
by PP2AT55a
The 224KKVAVVRTPPKSP236 peptide of Tau interacts
directly with the PR55/Ba subunit, and is able to compete with
native Tau for binding to PP2AT55a [34]. Concordantly, the
substrate binding groove of PR55/Ba shows a negative character,
suggesting a charge-charge interaction between both proteins.
Charge-inverting mutations on PR55/Ba indeed led to a decreased
level of catalytic efficiency of the holoenzyme [19]. Phosphoryla-
tion of the T231 residue would be expected to diminish the positive
character of the Tau peptide, and might hence also modulate this
interaction and possibly the enzymatic efficiency of the holoen-
zyme. Measuring the dephosphorylation of a phospho-Tau T231A
sample with 1 unit of PP2AT55a phosphatase, we indeed found an
increased dephosphorylation rate compared to the wild type
phospho-Tau, with a gain of more than two-fold for pT153 and
pT205 (Table 1). With this low amount of phosphatase, the pS202
position that was not dephosphorylated in the wild type phospho-
Tau sample after 16 hours, becomes almost completely dephos-
phorylated in the phospho-Tau T231A (Fig. 5, compare panels A
and C). The phosphorylation status of the AT180 epitope hence
influences directly the PP2AT55a catalyzed dephosphorylation rate
of phospho-Tau and most strikingly of the AT8 epitope.
Regulation of the PP2AT55a activity by Pin1
Using a cdc2 phosphorylated Tau as substrate, Zhou et al.
described a stimulatory effect of Pin1 on the dephosphorylation
activity of PP2AT55a [27]. Dephosphorylation of phospho-Tau
T231A not being affected by Pin1 led to the hypothesis that the
phosphate release assay used in that study monitored the
Figure 3. Regulation of the dephosphorylation of the AT8
epitope. Details of the 2D spectra (in red) of phospho-Tau (pTau, A, C,
D) and phospho-Tau S202AS199A (pTauS202AS199A, B) after 16 hours
of incubation at 25uC (293K) with 1U (A, B) or 3.5U PP2AT55a (C) and
3.5U of PP2AD (D). The spectra are superimposed on the spectrum of
the unmodified Tau protein (in gray). T205(pS202) stands for the amide
resonance of T205 with a pS202 neighbour in the Tau molecule.
doi:10.1371/journal.pone.0021521.g003
Figure 4. Kinetic of dephosphorylation of phospho-Tau by the
heterotrimeric PP2AT55a. The dephosphorylation kinetics are ob-
tained by integration of the cross peak of the amide function of the
corresponding phospho-residue in the consecutive [
1H,
15N] 2D spectra
encompassing 60 min. of the in-spectrometer reaction at 25uC (293K).
The graph shows the differential dephosphorylation by PP2AT55a (3.5
units) of phospho-Tau. Fitting of the data by a mono-exponential curve
yielded the time constants T (min.) reported in Table 1. pT231 is
represented by stars, pS199 by triangles and G207(pT205) by crosses.
G207 stands for G207 next to a pT205 in the Tau molecule.
doi:10.1371/journal.pone.0021521.g004
Figure 5. Regulation of the dephosphorylation of the AT8
epitope. Details of the 2D spectrum (in red) of CDK2/CycA3 phospho-
Tau (pTau, A and B) and phospho-Tau T231A (pTauT231A, C and D)
after 16 hours of incubation at 25uC (293K) with PP2AT55a (1U)
superimposed on the spectrum of the unmodified Tau protein (in
gray). pTau and pTauT231A correspond to dephosphorylation without
Pin1 (A and C) and pTau/Pin1 and pTauT231A/Pin1 with an excess of
Pin1 (B and D).
doi:10.1371/journal.pone.0021521.g005
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role of Pin1 through its cis/trans isomerase activity at this precise
pT231-Pro motif [27]. Our result that pT231 is at best marginally
dephosphorylated by PP2AT55a (Fig. 2, 4) prompted us to re-
examine the precise role of Pin1 in the framework of Tau
dephosphorylation by PP2AT55a. Because the interaction with
Pin1 (and most probably its WW domain, [35]) broadens the
NMR signals of the phospho-resonances beyond detection, we
monitored the PP2A kinetics through the appearance of the non-
phosphorylated forms. The rate of dephosphorylation of pT205
(T=160 min.) was indeed increased 3 fold by the presence of a
threefold excess of Pin1 (T=55 min.), which is the same ratio
of Pin1:phospho-Tau as used in the initial report [27]. Remark-
ably, pS202, although not dephosphorylated at all by 1 unit of
PP2AT55a, is completely dephosphorylated in the presence of Pin1
(Fig. 5, compare panels A and B). This stimulatory effect of
Pin1 is however selective, as the dephosphorylation of pT231,
monitored by the appearance of the R230(T231) peak, is still
negligible.
We next monitored the dephosphorylation of the same phospho-
Tau by PP2AD in the absence or presence of Pin1. Although
already of reduced activity when compared to PP2AT55a (Fig. 3,
compare panels C and D), the efficiency of the core enzyme
slowed down even further upon the addition of Pin1 (Fig. S2). We
finally tested the effect of Pin1 on the enzymatic efficiency of the
PP2AT55a phosphatase complex towards the phospho-Tau T231A
mutant. The dephoshorylation of the complete AT8 epitope was
faster than in the wild type phospho-Tau (Fig. 5, compare
panels A and D), but was not further stimulated by Pin1 (Fig. 5,
compare panels C and D).
Discussion
Tau phosphorylation is a reversible process that regulates in a
complex manner its physiological role of microtubule stabilization.
It is also linked to its pathological role, as the neurofibrillary
tangles found inside the neurons of AD patients invariably contain
a hyperphosphorylated form of Tau. Analysis with specific anti-
bodies have shown that the latter form is characterized by the
simultaneous presence of multiple phosphorylated residues, includ-
ing the S202/T205 and T231 positions that constitute respectively
the AT8 and AT180 epitopes [2]. These phosphorylation events
seemingly follow a hierarchical appearance, T231 being one of
the earliest sites to be phosphorylated in AD brain before the
epitope recognized by the AT8 antibody [4], [36]. In the axon,
PP2AT55a is associated with the microtubules [34], and its phos-
phatase activity counteracts the appearance of this multiply phos-
phorylated Tau [29]. In addition, it has recently been reported that
other neuronal PP2A heterotrimers might indirectly contribute to
Tau phosphorylation/dephosphorylation by regulating the activ-
ities of GSK3b and CDK5 kinases [37]. However, at a certain
stage of the disease, this kinase-phosphatase balance breaks down,
and one does observe the accumulation of hyperphosphorylated
Tau in the somato-dendritic compartment [29], [38], [39].
In this report, we investigate at the molecular level the enzy-
matic dephosphorylation of Tau by PP2AT55a, the major brain
isoform of PP2A directly associated to microtubules and Tau [16],
[34], and ask whether certain phosphorylation events on Tau
might exert an effect towards its activity at other sites. Our in vitro
set-up with CDK2/CycA3 kinase generating the AT8 and AT180
epitopes on recombinant
15N-labelled Tau [30] and concomitant
NMR analysis gives a global view of the Tau phosphorylation
pattern as a function of time. We thereby find that PP2AT55a
selectively targets certain Tau phosphorylation sites, with fast
dephosphorylation of the pT205 and pT153 sites but hardly any
for pT231 (Table 1). Whereas inefficient dephosphorylation of
pT231 was previously described for PHF-Tau [40], our finding of
efficient dephosphorylation for the pT153 site has not yet been
described in the literature because of the absence of specific anti-
body. This underscores the advantage of the global view conferred
by our NMR approach.
The dimeric PP2AD (PP2A AC) isoform has a lower catalytic
efficiency on all Tau phospho-sites compared to the heterotrimeric
PP2AT55a, emphasizing the crucial role of the B subunit in the
function of the PP2A holoenzyme. A correlation between the
interaction of Tau with the PR55/Ba subunit and the catalytic
efficiency of PP2AT55a was previously described [34], [41], and
has recently obtained a molecular basis with the crystal structure of
the PP2AT55a holoenzyme [19]. The b-propeller constituting the
PR55/Ba subunit indeed contains an acidic groove constituting a
potential binding site for the basic 224KKVAVVRTPPKSP236
Tau peptide that can compete with full-length Tau for binding to
PP2A [34]. In this mode of interaction, the PR55/Ba regulatory
subunit would thus play a role in anchoring the enzyme to its
substrate, or alternatively, would exert an allosteric stimulatory
effect as observed for protamine or poly-lysine [23]. We did
observe that all sites were more rapidly dephosphorylated in the
phosphorylated Tau T231A, implying that phosphorylation at the
T231 position reduces the PP2A activity. Phosphorylation at this
position could modulate the binding mode of the PR55/Ba
subunit leading to the inhibition of the PP2A activity. The recent
discovery of a-endosulfine or Arpp-19, that both require phos-
phorylation of S67 by the Greatwall kinase within the already
acidic peptide D66SGDD69 in order to efficiently interact with the
PR55/Bd subunit of the Xenopus mitotic PP2A heterotrimer
[26], [25], suggests that different binding modes to the PR55/B
regulatory subunits may exist. Phosphorylation of T231, be it by
GSK3b after CDK5 priming at the S235 position [8], [9] or by
another kinase combination, thus stimulates the phosphoryla-
tion at the AT8 epitope via negative feedback on PP2AT55a
phosphatase activity. This potentially can lead to a stable state
with both epitopes phosphorylated [42], as is found in AD
neurons [2].
An additional level of regulation has been described for the
phospho-dependent prolyl cis/trans isomerase Pin1 [43]. Here, we
confirm the stimulatory effect of Pin1 on the PP2AT55a catalyzed
dephosphorylation of wild type phospho-Tau and its absence in
the Tau T231A mutant. Stimulation was most striking for the
pS202 site, switching from no dephosphorylation with one unit of
PP2AT55a in the absence of Pin1 to complete dephosphorylation in
its presence. The effect is however not homogeneous, with at best a
weak activity of PP2AT55a towards pT231 despite the presence of
Pin1. Moreover, the stimulatory effect directly depends on the
PR55/Ba subunit, as Pin1 rather hinders than stimulates the
activity of the dimeric core enzyme. Pin1 hence counterbalances
the negative regulation of PP2AT55a activity towards the AT8 site
following phosphorylation of the AT80 pT231 site, in agreement
with the inverse correlation between Pin1 expression and actual
neurofibrillary degeneration in AD [28]. Because PP2AT55a has
been shown to regulate the phosphorylation status of Tau in vivo,a
potential trigger for PHF formation might be a shift of the balance
between neuronal kinases and phosphatases. Our results show that
phosphorylation of T231 directly influences the dephosphorylation
rate of pS202, without necessitating an alteration in the PP2AT55a
pool. We have reconstituted here the complex system of phos-
phorylated Tau and the trimeric PP2AT55a phosphatase in the
NMR tube with several recombinant proteins, and thereby
unravelled a subtle regulatory mechanism. An additional level of
PP2A and Pin1 in Hyperphosphorylation of Tau
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The phosphorylation/dephosphorylation reactions in vivo might
even be more complex, because of the presence of tubulin and/or
other regulatory factors, but even these can be added in the NMR
tube [44]. Whereas we previously showed that NMR observation
of Tau in live Xenopus ovocytes is feasible [45,46], we believe that
both approaches will bring novel insights in the complex regu-
lation of multi-site phosphorylation.
Materials and Methods
Expression and purification of Recombinant proteins
Preparation of the recombinant Tau proteins, isotopic enrich-
ment and phosphorylation are described in [30], [32]. The Pin1
protein was expressed as a His Tag fusion from a pET15b plasmid
in BL21(DE3) E. coli strain [47]. The His Tag was not removed
before the assays.
Preparation of CDK2-CycA3 phospho-Tau
CDK2/CycA3 were prepared as described in [48] except that
the bacterial extracts containing recombinant GST-CDK2pT160
(Gluthathion S transferase fusion protein) and CycA3 were mixed
before being applied on a Glutathion sepharose FF (5 ml, GE
Healthcare). The CDK2/CycA3 complex was recovered from the
resin by proteolysis, performed at 4uC overnight with the Pre-
Scission protease (GE Healthcare) directly on the Glutathion
Sepharose beads in buffer 50 mM Tris pH 8.0, 20 mM NaCl,
1 mM EDTA, 1 mM DTT. The concentration of the complex
was evaluated at 280 nm with an extinction coefficient e of
67420 M
21cm
21. The complex was kept frozen at 280uC in this
buffer until used.
Purification of dimeric and trimeric PP2A
Purification of PP2AD and PP2AT55a from rabbit skeletal
muscle is described in [23]. Calibration of the activity was done
using the standard PP2A substrate phosphorylase a [23]. One unit
is defined as the activity corresponding to removal of 1 nmole/min
of
32P-phosphate at 30uC.
NMR sample preparation
NMR buffer was 25 mM Tris-d11, 25 mM NaCl, 2.5 mM
EDTA, 1 mM DTT, pH 6.8. Dephosphorylation of 20 mMo f
CDK2/CycA3 phospho-Tau (or Tau mutants), as defined by
absorption at 280 nm, was performed in a volume of 160 mli n
3 mm NMR tubes. Samples with Pin1 are 20 mM phospho-Tau/
60 mM Pin1. The PP2A enzyme diluted in 20 ml buffer was
directly added in the NMR tube to 140 ml of the phospho-Tau,
immediately before starting acquisition of the 2D spectra series.
NMR spectroscopy
Spectra were acquired at 293K on a 800 MHz equipped with a
3 mm Probe. Parameters of the [
1H,
15N]-HSQC (HeteroNuclear
Single Quantum Spectroscopy) were 32 scans, 2048 points in the
direct dimension and 128 points in the indirect dimension. An
optimized d1 of 0.8 s was used. The [
1H,
15N]-HSQC are named
2D spectra in the text.
Data analysis
The peak integrals (Data S1) were normalized against an
invariant and intense peak in the spectrum corresponding to A85,
set to 1 in the integration. Integration was performed with the
Topspin 2.1 software (Bruker, Karlsruhe, Germany). Integral data
were fitted with a mono-exponential function.
Supporting Information
Figure S1 Identification of the phospho-sites of CDK2/
CycA3 phospho-Tau. Superimposition of the [
1H,
15N] 2D
spectra of the Tau protein (black) and of the CDK2/CycA3
phospho-Tau protein (red). Inset: the enlarged region of the
spectrum illustrates phosphorylation of residues S202 and T205.
(PDF)
Figure S2 Regulation of the dephosphorylation of the
pS202/pT205 AT8 epitope. Details of the 2D spectrum (in red)
of CDK2/CycA3 phospho-Tau after 16 hours of incubation at
25uC (293K) with PP2AD (3.5 U) superimposed on the spectrum
of the unmodified Tau protein (in gray). A dephosphorylation
without Pin1 and B in presence of an excess of Pin1.
(PDF)
Data S1 Step by step procedure of NMR data treat-
ment. I. A serie of 2D spectra is acquired, in this example we
limited the serie to the first five 2D spectra. The first one in the
serie is the control experiment without enzyme and is time zero or
starting point in the in spectrometer kinetics of dephosphorylation.
The following 2D spectra, after the addition of the enzyme, are
acquired successively while the NMR tube remains in the
spectrometer. This experimental dataset corresponds to the one
presented in Fig. 2 and Fig. 4. II. Each 2D spectrum required 63
minutes for acquisition. Each data-point is thus obtained every 63
minutes: that is the time resolution in this experiment. III. The
succession of the 2D spectra will allow to follow the kinetics of the
reaction. Duration of each spectrum is cumulated. In this example,
we cover with the five 2D spectra 252 minutes of the enzymatic
reaction. IV. The surface of a peak in a boxed area in the 2D
spectra (see point I) or Integrals is calculated by TOPSPIN2.1
Bruker software. This value is directly related to the amount of the
corresponding amino acid residue in solution. We follow the
evolution of the peak surface or Integral for each amino acid
residue of interest (I1 to I4) during the reaction, as detected in each
successive spectrum. In our example, I1 corresponds to pT153, I2
to pT231 and I3 to A152. I4 is linked to the resonance of amino
acid residue A77. V. Data of integration is normalized against
integral value of A77 (I4), an invariant and intense peak in the
spectra, in order to compensate for any variation of intensity due
to potential spectrum to spectrum modification of conditions (for
example, addition of the enzyme). VI. Data are normalized
against the highest integral value of the kinetics for each amino
acid residue. In that way, the starting point or ending point of the
kinetics is set to one, allowing easier comparison of the evolution of
the amount of various amino acid residues during the course of the
enzymatic reaction. VII. A final table is obtained containing the
normalized integral values for each time-point in the kinetics.
VIII. For each amino acid residue, an exponential curve is fitted
to the experimental data by adjusting the value T in the expo-
nential formula e
(-t/T). The value T is found by minimizing the
sum of the square differences between the calculated and observed
data (compare table values in VII and VIII). This constant
characterizes the rate of dephosphorylation and is reported in
Table 1. A scaling factor (0.8) as well as a residual value depending
of the extent of dephosphorylation (0.2 or 0.1) is also used to adjust
the formula to the data. Values in the table IX are calculated
based on the formula in the left column for pT153 (decreasing
exponential) and A152 (increasing exponential). IX. Data-points
from table in VII are graphically represented with the axis being
the time-points (each 2D spectrum) and the ordinate the nor-
malized integral value for each time-point (spectrum) reported for
several amino acid residue of interest. In this example, pT153 or
PP2A and Pin1 in Hyperphosphorylation of Tau
PLoS ONE | www.plosone.org 6 June 2011 | Volume 6 | Issue 6 | e21521I1 (open squares) shows a decrease of its initial integral value or
peak surface that can be interpreted as a decrease of the cor-
responding chemical species in solution, in this case due to the
dephosphorylation by PP2A. The resonance of A152 (black dots)
shows accordingly an increase of its integral value. pT231 integral
value remains unaffected throughout the in spectrometer enzymatic
reaction (stars). The fitted exponential curves are represented
by lines.
(PDF)
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